Key Horizon drug Tepezza has hearing loss warning added to labeling

Key Horizon drug Tepezza has hearing loss warning added to labeling

Submitted by admin on July 20, 2023 - 9:46pm
Source: 
Seeking Alpha
News Tags: 
Horizon Therapeutics
Tepezza
hearing loss
thyroid eye disease
Headline: 
Key Horizon drug Tepezza has hearing loss warning added to labeling
snippet: 

The US FDA has added a warning about the potential for severe hearing impairment including hearing loss associated with Horizon Therapeutics' (NASDAQ:HZNP) Tepezza (teprotumumab). Horizon fell 2.7% amid the news on Thursday.

Do Not Allow Advertisers to Use My Personal information